Clinical Trials in Baltimore

Showing 8941-8960 of 23,476 trials

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

NCT05096754

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.

TransMedics74 participantsStarted Feb 2020

La Jolla, California, United States • La Jolla, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

NCT03496012

The objective of the study is to evaluate the efficacy and safety of a single sub-retinal injection of BIIB111 in participants with choroideremia (CHM).

Choroideremia

Biogen169 participantsStarted Dec 2017

Los Angeles, California, United States • Miami, Florida, United States • Baltimore, Maryland, United States +15 more locations

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

Find Trials by Condition in Baltimore

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Neuroimmune Dysfunction in Alcohol Use Disorder

HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma

Determining Age Appropriateness of Children's Products and Toys

Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency

Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

Exercise Program in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population

Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

Trident II Revision Outcomes Study

Air Pollution: Strategies for Personalized Intervention to Reduce Exposure

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Examine the Psychosocial Impacts of COVID-19 Pandemic.

International Lung Screen Trial (ILST)